Anzeige
Mehr »
Login
Sonntag, 05.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
InnoCan Pharma: Multi-Milliarden-Wert in diesem Pennystock?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
396 Leser
Artikel bewerten:
(2)

EXTENDED HEALTH: Noverca Enters the World of Healthcare / Noverca's 2.0 - A mobile platform for the monitoring and management of diabetes

ROME, April 8, 2011 /PRNewswire/ -- Noverca - the first and currently only Italian 'Full MVNO' - has expanded its product offerings by announcing its presence in the Health and Wellness Sector.

An innovative telematic support model to support diabetes treatment has been developed and launched thanks to the long-term partnership between Acotel Group (Parent company of Noverca) and Fatebenefratelli Hospital. Davide Carnevale, Marketing & Sales Director at Noverca Italia, made the announcement during an Italy Expo Comm Italia 2011 press conference.

The telematic support product ensures a constant monitoring solution which enables patients to access their own health activity data on multiple channels including SMS, web, and Smartphone applications, and allows them to share the data with others, including doctors and family, resulting in heightened awareness and overall superior care.

"The partnership with Fatebenefratelli and the monitoring of diabetic patients is only the first step into the world of Healthcare," said Davide Carnevale. "Moreover, we are ready to cover many other aspects of the Health and Wellness field."

At the heart of the Noverca system is the patent pending MiniMAU (Management Automation Unit) with embedded SIM Noverca 2.0. The MiniMAU operates as a patient data access point to the GSM network and interfaces, via either IrDA, Bluetooth, or USB, with medical devices used by patients (e.g. glucometers) while communicating with the central platform.

The platform processes data relating to medical indicators of the patient and provides a full range of analyses useful for diagnostic and management purposes. If requested, the platform will automatically send alerts via SMS and/or email, thereby permitting healthcare professionals to intervene and modify treatment in real time.

"In addition to our numerous mobile phone services," Davide Carnevale continues, "We will shortly be launching additional 2.0 services in the Health & Wellness, Security and Energy Control management sectors, as well as introducing a new and important concept of social networking."

About Acotel Group: Acotel Group, parent company to Flycell, Jinny Software, Info2cell, & Noverca Italia, is a global provider of multimedia platforms and applications to mobile network operators and media companies around the world. Through its customer base, Acotel services more than 35 million end users, and enabled 340 million paid text and multimedia messages in 2002. Founded in 1992, Acotel operates in 20 countries and is publicly traded on the Milan Stock Exchange.

Press Office Press Office Communication Area -Noverca Cast Adv. & Communication Italia pressoffice@castadv.it Alessandro Masciarelli Tel.+ 39 06.33252983 alessandro.masciarelli@noverca.it Adriano Conti, Daniela Primerano, Stefania Caucci Tel. + 39 06.61143000

Who is Noverca Italia: Noverca Italia (www.noverca.it) is a company born out of the industrial cooperation starting in 2008 between the Acotel Group and the banking Group Intesa Sanpaolo. The company is one of the main Italian virtual mobile operators and has always been distinguished by its ability to introduce services with high added value onto the market.

Noverca Italia

Web site: http://www.noverca.it/

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2011 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.